Kinetoplast DNA
Nucleic acid in Trypanosoma brucei that 2 drugs act on.
- Drugs that act on it: 2
- Approved: 1
- In phases 1 to 3: 1
- Sponsors: 2
Who is on it, and how far along
Every drug ChEMBL records acting on this target, by the furthest stage it has reached for any use, coloured by modality.
How to read this
Each mark is one drug. Columns run from approved to phase 1; hover or tap a mark for its sponsor, modality and open trials, and click it to open the drug.
- Small molecule 2
| Pentamidine | Approved | Merck & Co. (MSD) | Small molecule | InhibitorKinetoplast DNA inhibitor | 5 |
| Pafuramidine | Phase 3 | Immtech Pharmaceuticals, Inc | Small molecule | InhibitorKinetoplast DNA inhibitor | 0 |
| A Clinical Trial of MK-1045 With Zilovertamab Vedotin in Participants With Diffuse Large B-cell Lymphoma (MK-1045-010) | Pentamidine | Phase 2 / Phase 3 | Not yet recruiting | Merck Sharp & Dohme LLC | Nov 5, 2026 |
| Modified FOLFIRINOX and Pentamidine in Advanced and Metastatic Pancreatic Cancer | Pentamidine | Phase 1 | Recruiting | University of Oklahoma | Sep 18, 2026 |
| Study Comparing Several Drugs to Understand Which Work Against Cutaneous Leishmaniasis (CL) | Pentamidine | Phase 3 | Not yet recruiting | Institute of Tropical Medicine, Belgium | Mar 10, 2026 |
| Positioning Second-line Therapies for Pneumocystis Jirovecii Pneumonia (PCP Alternatives) | Pentamidine | Phase 4 | Not yet recruiting | McGill University Health Centre/Research Institute of the McGill University Health Centre | Jan 21, 2026 |
| Treatment of Bolivian L Braziliensis Mucosal Leishmaniasis With Inhaled Pentamidine Plus Oral Miltefosine | Pentamidine | Phase 2 | Recruiting | Fundacion Nacional de Dermatologia | Aug 13, 2024 |
Drugs, mechanisms, furthest stage (max phase) and modality (molecule type) are from ChEMBL CHEMBL2366047, ChEMBL 37, fetched 2026-11-18 (CC BY-SA 3.0). Sponsors are the US application holder (Drugs@FDA) for approved drugs with a US page, else the industry lead sponsor of the most of the drug's ClinicalTrials.gov trials. Open trials are recruiting or ongoing studies naming the drug as an intervention on ClinicalTrials.gov, checked daily; this page as of 2026-11-22. ChEMBL and Open Targets